miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer

Published:2016-12 Issue:12 Volume:7 Page:e2503-e2503
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Wang Xiao,Liang Zhen,Xu Xin,Li Jiangfeng,Zhu Yi,Meng Shuai,Li Shiqi,Wang Song,Xie Bo,Ji Alin,Liu Ben,Zheng Xiangyi,Xie Liping

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2016373.pdf

Reference43 articles.

1. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

2. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 234–241.

3. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666–675.

4. Choueiri TK, Raghavan D . Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties. Nat Clin Pract Oncol 2008; 5: 444–454.

5. Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia;Genes;2024-08-10

2. Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers;Pathology - Research and Practice;2024-07

3. A study of microRNAs as new prognostic biomarkers in anal cancer patients;Acta Oncologica;2024-06-20

4. MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer;Biochemical and Biophysical Research Communications;2024-02

5. A review on recent advances in assays for DNMT1: a promising diagnostic biomarker for multiple human cancers;The Analyst;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3